CClinicalTrials.gg
CompletedNCT02869334Updated Jul 8, 2021Results posted

Remediation of Auditory Recognition in Schizophrenia With tDCS

An interventional study of Active Transcranial direct current stimulation (tDCS) and Sham Transcranial direct current stimulation (tDCS) in Schizophrenia and Schizoaffective Disorder, sponsored by New York State Psychiatric Institute. Completed at 1 site in United States. Open to participants aged 18 Years to 55 Years. Per ClinicalTrials.gov, last updated 2021-07-08.

Sponsored by New York State Psychiatric Institute · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
20
Allocation
Randomized
Ages
18 Years to 55 Years
Sex
All
01

Study summary

The purpose of this study is to determine whether transcranial direct current stimulation (tDCS), when combined with different forms of computer based training, improves the ability to discriminate small differences between sounds in people diagnosed with schizophrenia or schizoaffective disorder.

Read the detailed description

This study uses an experimental procedure called transcranial direct current stimulation (tDCS). Little is known about how tDCS affects the brain or why some people diagnosed with schizophrenia or schizoaffective disorder have trouble with certain kinds of hearing. This study is being done to see if an experimental computer training program, when combined with tDCS, can help people to hear better. In tDCS, a small amount of electricity is passed through electrodes placed on the head that is able to stimulate the brain. By stimulating the brain, the investigators believe that the functioning of the brain can be altered. This study will test whether such stimulation of the brain, when done with computer training, can improve hearing ability and if this improvement helps in other ways, like detecting changes in someone's tone of voice or understanding other people's emotions better. The data being collected aims to better understand how the brain processes sounds and how tDCS affects the brain.

02

Conditions studied

  • Schizophrenia
  • Schizoaffective Disorder
03

In context

Schizophrenia

3,471 studies on the registry are indexed under Schizophrenia; 472 are open to participants now.

This study's enrollment of 20 is below the median of 70 across 2,872 interventional studies indexed under Schizophrenia.

Browse Schizophrenia studies →

Lead sponsor

New York State Psychiatric Institute is the lead sponsor of 425 studies on the registry; 26 are open to participants now.

Of its 50 completed or terminated interventional studies of FDA-regulated products, 45 (90%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 55 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Age 18-55
  • Primary diagnosis of Schizophrenia or schizoaffective disorder
  • English fluency
  • Willing/capable to provide informed consent
  • Auditory tone matching deficits
  • Receiving stable doses of antipsychotic medication(s) for at least 2 weeks
  • IQ>75

Exclusion criteria

Exclusion Criteria:

  • Serious neurological disorder or medical condition/ treatment known to affect the brain. Neurological Disorder that affects the central nervous system (CNS), such as epilepsy, neurodegenerative disorders, movement disorders and sensory disorders.
  • Current or past history (within the last 6 months) of substance abuse or dependence (excluding nicotine)
  • Pregnancy or breastfeeding
  • Taking anticholinergic medication (e.g. Cogentin, Thorazine, Clozaril, thioridazine)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Quadruple (Participant, Care provider, Investigator, Outcomes assessor)
Enrollment
20 participants (actual)

Study arms

  • Experimental
    Auditory remediation with active tDCS

    Auditory remediation program paired with active transcranial direct current stimulation (tDCS) for 30 minutes, 2-3 sessions per week

    Device: Active Transcranial direct current stimulation (tDCS) · Behavioral: Auditory Remediation

  • Experimental
    Auditory remediation with sham tDCS

    Auditory remediation program paired with sham transcranial direct current stimulation (tDCS) for 30 minutes, 2-3 sessions per week

    Device: Sham Transcranial direct current stimulation (tDCS) · Behavioral: Auditory Remediation

  • Sham comparator
    Control (computer games with sham tDCS)

    Non-remediation, control computer activities (e.g. games) with sham transcranial direct current stimulation (tDCS) for 30 minutes, 2-3 sessions per week

    Device: Sham Transcranial direct current stimulation (tDCS) · Behavioral: Control computer activities

Interventions

  • DeviceActive Transcranial direct current stimulation (tDCS)

    Active tDCS, where an extremely weak electric current passes through the brain

  • DeviceSham Transcranial direct current stimulation (tDCS)

    Sham (inactive or placebo) tDCS

  • BehavioralAuditory Remediation

    Computer program designed to improve discrimination between sounds

  • BehavioralControl computer activities

    Computer program (e.g. games), which are not designed to improve discrimination between sounds

06

What researchers measure

Primary outcomes

  1. Auditory Tone Matching Task

    Ability to match tones following brief delay

    Time frame: Change in performance from Baseline at completion of training (week 16)

Secondary outcomes

  1. Auditory Emotion Recognition (AER) Task

    Ability to detect emotion based on tone of voice

    Time frame: Change in performance from Baseline at completion of training (week 16)

  2. ER-40

    Penn Emotion Recognition Test-40 Faces Version

    Time frame: Change in performance from Baseline at completion of training (week 16)

  3. The Awareness of Social Inference Test (TASIT)

    The TASIT is a measure of social cognition, theory of mind as reflected in the ability to detect lies/sarcasm while viewing social vignettes. Total scores range from 0-100% correct. Higher numbers (positive change) are considered better.

    Time frame: Change in performance from Baseline at completion of training (week 16)

  4. Auditory Mismatch Negativity (MMN)

    Change in event related potentials (ERP) acquired during a task of auditory mismatch negativity (MMN), assessed with electroencephalography (EEG)

    Time frame: Change in performance from Baseline at completion of training (week 16)

07

Results

Posted Jul 8, 2021

Participant flow

Participant flow — Overall Study
MilestoneAuditory Remediation With Active tDCSAuditory Remediation With Sham tDCS
Started1010
Completed23
Not completed87

Outcome measures

PrimaryAuditory Tone Matching Task

Ability to match tones following brief delay

Time frame:
Change in performance from Baseline at completion of training (week 16)
Reported as:
Mean · %correct, different trials
Auditory Tone Matching Task
%correct, different trialsAuditory Remediation With Active tDCSAuditory Remediation With Sham tDCS
Auditory Tone Matching Task-4.3 ± 12.14.8 ± 9.3
SecondaryAuditory Emotion Recognition (AER) Task

Ability to detect emotion based on tone of voice

Time frame:
Change in performance from Baseline at completion of training (week 16)
Reported as:
Mean · %correct
Auditory Emotion Recognition (AER) Task
%correctAuditory Remediation With Active tDCSAuditory Remediation With Sham tDCS
Auditory Emotion Recognition (AER) Task-3.0 ± 8.65.1 ± 12.2
SecondaryER-40

Penn Emotion Recognition Test-40 Faces Version

Time frame:
Change in performance from Baseline at completion of training (week 16)
Reported as:
Mean · percent correct
ER-40
percent correctAuditory Remediation With Active tDCSAuditory Remediation With Sham tDCS
ER-40-5.0 ± 3.5-1.3 ± 1.8
SecondaryThe Awareness of Social Inference Test (TASIT)

The TASIT is a measure of social cognition, theory of mind as reflected in the ability to detect lies/sarcasm while viewing social vignettes. Total scores range from 0-100% correct. Higher numbers (positive change) are considered better.

Time frame:
Change in performance from Baseline at completion of training (week 16)
Reported as:
Mean · score on a scale
The Awareness of Social Inference Test (TASIT)
score on a scaleAuditory Remediation With Active tDCSAuditory Remediation With Sham tDCS
The Awareness of Social Inference Test (TASIT)10 ± 4.20 ± 6.8
SecondaryAuditory Mismatch Negativity (MMN)

Change in event related potentials (ERP) acquired during a task of auditory mismatch negativity (MMN), assessed with electroencephalography (EEG)

Time frame:
Change in performance from Baseline at completion of training (week 16)
Reported as:
Mean · microvolt
Auditory Mismatch Negativity (MMN)
microvoltAuditory Remediation With Active tDCSAuditory Remediation With Sham tDCS
Auditory Mismatch Negativity (MMN)-1.47 ± 0-.98 ± 1.07

Adverse events

Collected over 16 weeks. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Auditory Remediation With Active tDCS0/2 (0%)0/2 (0%)1/2 (50%)
Auditory Remediation With Sham tDCS0/3 (0%)0/3 (0%)0/3 (0%)
Most frequent other events
Most frequent other events
EventAuditory Remediation With Active tDCSAuditory Remediation With Sham tDCS
sedationNervous system disorders1/20/3

Baseline characteristics

Age, Categorical
Age, Categorical(Participants)Auditory Remediation With Active tDCSAuditory Remediation With Sham tDCSTotal
<=18 years000
Between 18 and 65 years235
>=65 years000
Age, Continuous
Age, Continuous(years)Auditory Remediation With Active tDCSAuditory Remediation With Sham tDCSTotal
Mean39.0 ± 9.944.7 ± 14.442.4 ± 11.8
Sex: Female, Male
Sex: Female, Male(Participants)Auditory Remediation With Active tDCSAuditory Remediation With Sham tDCSTotal
Female112
Male123
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)Auditory Remediation With Active tDCSAuditory Remediation With Sham tDCSTotal
Hispanic or Latino112
Not Hispanic or Latino123
Unknown or Not Reported000
Race (NIH/OMB)
Race (NIH/OMB)(Participants)Auditory Remediation With Active tDCSAuditory Remediation With Sham tDCSTotal
American Indian or Alaska Native000
Asian000
Native Hawaiian or Other Pacific Islander000
Black or African American224
White011
More than one race000
Unknown or Not Reported000
Region of Enrollment
Region of Enrollment(participants)Auditory Remediation With Active tDCSAuditory Remediation With Sham tDCSTotal
United States235
Tone matching (i.e. ability to match tones following brief delay)
Tone matching (i.e. ability to match tones following brief delay)(percent correct)Auditory Remediation With Active tDCSAuditory Remediation With Sham tDCSTotal
Mean53.6 ± 5.154.3 ± 12.754.0 ± 9.3
08

Study locations

1 site
  • New York State Psychiatric Institute
    New York, New York 10032, United States
09

References and documents

Publications

  • Roberts MT, Lloyd J, Valimaki M, Ho GW, Freemantle M, Bekefi AZ. Video games for people with schizophrenia. Cochrane Database Syst Rev. 2021 Feb 4;2(2):CD012844. doi: 10.1002/14651858.CD012844.pub2. PubMed 33539561 ↗

Study documents

  • Protocol and statistical analysis plan · Oct 27, 2016

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

10

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jul 8, 2021, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT02869334
Lead sponsor
New York State Psychiatric Institute
Collaborators
Nathan Kline Institute for Psychiatric Research
Responsible party
Daniel C. Javitt (Professor, New York State Psychiatric Institute) — Principal investigator
First posted
Aug 16, 2016
Start date
Jun 2016
Primary completion
Jan 31, 2020
Completion
Jan 31, 2020
Results posted
Jul 8, 2021
Last update
Jul 8, 2021

Study contacts

Daniel Javitt, MD, PhD
principal investigator · NY State Psychiatric Institute, Columbia University

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jun 2021. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion